SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-046006
Filing Date
2019-12-16
Accepted
2019-12-16 07:01:46
Documents
12
Period of Report
2019-12-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets

Document Format Files

Seq Description Document Type Size
1 8-K crsp-8k_20191213.htm   iXBRL 8-K 47304
  Complete submission text file 0001564590-19-046006.txt   171596

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA crsp-20191213.xsd EX-101.SCH 5968
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE crsp-20191213_lab.xml EX-101.LAB 17851
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crsp-20191213_pre.xml EX-101.PRE 10680
5 EXTRACTED XBRL INSTANCE DOCUMENT crsp-8k_20191213_htm.xml XML 3250
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37923 | Film No.: 191285844
SIC: 2836 Biological Products, (No Diagnostic Substances)